org placeholder image

Mary Dimarco

Director, Regulatory Operations at REGENXBIO

  • LinkedIn

Email Email: m****@regenxbio.com

phone noPhone Number: (***)-***-****

map
REGENXBIO

REGENXBIO

  • description Description
    REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV Technology Pl...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 250 Million to 500 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

REGENXBIO Org Chart and Mapping

Lisa Reid

Executive Assistant to Chief Executive Officer

Employees

Roseline Gobina

QA Compliance Specialist

Kelsey Wang

Manufacturing Engineer II

Nga Hilvano

Clinical Research Associate I

Valarie Cates

Manager, Clinical Quality Assurance

Don Startt

Senior Director, Upstream Process Development and Cmc Project Management

Catherine Wilson

Clinical Outcomes Research and Evaluation Contractor

Frequently Asked Questions Regarding Mary Dimarco

Answer: Mary Dimarco works for REGENXBIO as Director, Regulatory Operations

Answer: Mary Dimarco’s role in REGENXBIO is Director, Regulatory Operations

Answer: Mary Dimarco's email address is m***@gmail.com

Answer: Mary Dimarco's business email address is m****@regenxbio.com

Answer: Mary Dimarco’s direct phone number is (***)-***-****

Answer: Mary Dimarco works in the industry of: Biotechnology

Answer: Mary Dimarco works REGENXBIO located at 9804 Medical Center Dr, Rockville, Maryland, 20850, United States

Answer: REGENXBIO's Director, Regulatory Operations is Mary Dimarco

Answer: Mary Dimarco contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@regenxbio.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access